For the study, researchers examined 2012 data on preeclampsia from numerous population-based and administrative data sets, including the National Center for Health Statistics Vital Statistics on Births database, the U.S. Health Care Cost and Utilization Project database and a commercial claims data set.
Here are four study findings.
- Preeclampsia increases the likelihood of an adverse event from 4.6 percent to 10.1 percent for mothers and from 7.8 percent to 15.4 percent for infants.
- The most common adverse events in mothers were hemorrhaging and low blood platelet counts. Preeclampsia was most closely linked to respiratory distress syndrome and sepsis in infants.
- The condition lowers gestational age by 1.7 weeks.
- Preeclampsia costs the U.S. healthcare system an average of $1.03 billion for mothers and $1.15 billion for infants during the first 12 months after birth.
More articles on infection control and clinical quality:
Pre-op chemo may spur metastasis in breast cancer patients
At-home medication errors double in 13 years
Most Americans prefer paper towels to air dryers after washing hands
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
